FORMYCON AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41 EUR | +0.12% |
|
+4.86% | -27.30% |
| Apr. 25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Chart calendar Formycon AG
c0.4TsqGfrvYGGQgDWKjMD4kDhpDhJOrCbrYhuZMjhtQVk.rnlccZG5OQP99QDE-rnIpEwwVGc_9RSyNUqvUWcjDQyGXWY0ioEoN8n3fA~23c3b9dd6968c2a6339d1a2f8d24bb1a
Upcoming events on Formycon AG
Past events on Formycon AG
| 2024-04-25 09:00 am | Q4 2023 Earnings Call |
| 2024-04-24 | Q4 2023 Earnings Release |
| 2024-04-21 | Metzler Small Cap Day |
| 2024-03-18 | Jefferies Pan-European Mid-Cap Conference |
| 2024-03-11 | J.P. Morgan Pan-European Small/Mid-Cap CEO Conference |
| 2024-01-22 | AlsterResearch Pop-up-Conference Health Care |
| 2024-01-16 | UniCredit Kepler Cheuvreux German Corporate Conference |
| 2024-01-14 | Oddo BHF Forum |
| 2024-01-09 11:15 am | JPMorgan Healthcare Conference |
| 2023-11-26 | German Equity Forum |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-10-10 | Optimum Healthcare Investor Conference |
| 2023-09-26 | Goldman Sachs EMEA CFO Forum |
| 2023-09-26 | H.C. Wainwright ON TAP Biotech & Tech Conference |
| 2023-09-17 | Berenberg / Goldman Sachs German Corporate Conference |
| 2023-09-10 | H.C. Wainwright Global Investment Conference |
| 2023-08-29 | Q2 2023 Earnings Release |
| 2023-08-23 | Investor Day - Day 2 |
| 2023-08-22 | Investor Day - Day 1 |
| 2023-07-24 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 33,9 33,9 0% | 34,2 38,3 -10.71% | 37,0 40,9 -9.55% | 42,5 43,0 -1.17% | 77,7 77,7 0.04% | 59,3 |
|
EBITDA Million EUR | Released Forecast Spread | -1,40 -1,25 -12% | -4,81 -1,37 -251.95% | -12,4 -11,6 -7.11% | -15,9 -21,9 27.39% | 1,52 1,00 51.8% | -17,2 |
|
EBIT Million EUR | Released Forecast Spread | -2,30 -2,13 -8.24% | -5,73 -2,30 -148.91% | -13,3 -12,6 -5.64% | -17,7 -23,3 23.91% | -0,37 -6,00 93.85% | -22,1 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -2,29 -1,48 -55.12% | -5,92 -2,30 -157.53% | -13,5 -12,7 -5.79% | 36,6 -23,4 256.73% | 79,1 73,0 8.32% | -10,1 |
|
Net income Million EUR | Released Forecast Spread | -2,29 -1,54 -48.59% | -5,93 -2,37 -150.38% | -13,5 -12,7 -5.94% | 36,0 17,7 103.92% | 75,8 75,9 -0.14% | -16,0 |
|
EPS EUR | Released Forecast Spread | -0,23 -0,16 -46.36% | -0,54 -0,23 -137.66% | -1,22 -1,19 -2.63% | 2,59 1,21 114.05% | 4,72 0,00 - | -1,05 |
| Announcement Date | 18/05/20 | 17/05/21 | 18/05/22 | 27/04/23 | 25/04/24 | - |
Quarterly results
| Fiscal Period | December | 2023 S1 |
|---|---|---|
|
Net income Million EUR | Released Forecast Spread | 1,80 -3,31 154.47% |
|
EPS EUR | Released Forecast Spread | 0,11 -0,20 156.5% |
| Announcement Date | 30/08/23 |
More events
Past sector events for Formycon AG
| 2024-05-02 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FYB Stock
- Calendar Formycon AG
